Heteroaggregation of Antimicrobial Peptides LL 37 and HNP 1 Drives Cooperative Neutralization of Cytotoxicity JACS Au Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum JAAD Case Reports Real World Canadian Case Series: Use of Tildrakizumab for Moderate to Severe Psoriasis Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies Dermatology and Therapy Springer Nature Link Dermatology Treatments & Big Pharma A case series of early biologic therapy in guttate psoriasis: Targeting resident memory T cell activity as a potential novel therapeutic modality ScienceDirect